APA (7th ed.) Citation

Tanaka, E., Inoue, E., Shoji, A., Nilsson, J., Papagiannopoulos, C., Devender, D., . . . Harigai, M. (2020). AB1199 COST-EFFECTIVENESS OF EARLY INITIATION OF ABATACEPT ON JAPANESE RHEUMATOID ARTHRITIS PATIENTS BASED ON THE AMPLE STUDY, USING IORRA REAL WORLD DATA. Annals of the Rheumatic Diseases, 79(Suppl 1), 1890-1891. https://doi.org/10.1136/annrheumdis-2020-eular.540

Chicago Style (17th ed.) Citation

Tanaka, E., E. Inoue, A. Shoji, J. Nilsson, C. Papagiannopoulos, D. Devender, Y. Anazawa, Y. Yoshizawa, and M. Harigai. "AB1199 COST-EFFECTIVENESS OF EARLY INITIATION OF ABATACEPT ON JAPANESE RHEUMATOID ARTHRITIS PATIENTS BASED ON THE AMPLE STUDY, USING IORRA REAL WORLD DATA." Annals of the Rheumatic Diseases 79, no. Suppl 1 (2020): 1890-1891. https://doi.org/10.1136/annrheumdis-2020-eular.540.

MLA (9th ed.) Citation

Tanaka, E., et al. "AB1199 COST-EFFECTIVENESS OF EARLY INITIATION OF ABATACEPT ON JAPANESE RHEUMATOID ARTHRITIS PATIENTS BASED ON THE AMPLE STUDY, USING IORRA REAL WORLD DATA." Annals of the Rheumatic Diseases, vol. 79, no. Suppl 1, 2020, pp. 1890-1891, https://doi.org/10.1136/annrheumdis-2020-eular.540.